A Phase I Clinical Trial of RS001 in Patients with Relapsed/Refractory B-Cell Malignancies

Clinical trial NCT06894693 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06894693
Sponsor: Guangdong Ruishun Biotech Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Non-Hodgkin's Lymphoma Acute Lymphoblastic Leukemia

Start date: 2025-04-01
Primary completion: 2026-04-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.